NCT03151369

Brief Summary

The relationship between visual pain score and perfusion index in postoperative patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
89

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 18, 2017

Completed
Same day until next milestone

Study Start

First participant enrolled

April 18, 2017

Completed
24 days until next milestone

First Posted

Study publicly available on registry

May 12, 2017

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2018

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 19, 2018

Completed
Last Updated

February 20, 2018

Status Verified

February 1, 2018

Enrollment Period

9 months

First QC Date

April 18, 2017

Last Update Submit

February 19, 2018

Conditions

Perfusion

Outcome Measures

Primary Outcomes (1)

  • Perfusion index Perfusion index

    Measurement of perfusion on the right ring finger

    two times in one day

Secondary Outcomes (1)

  • visual analog scale

    two times in one day

Study Arms (1)

Morphine

OTHER

patients with the visual analog scale over 3 will receive morphine

Drug: Morphine

Interventions

MorphineDRUG

patients with the visual analog scale over 3 will receive morphine

Also known as: opioid analgesic
Morphine

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who underwent surgery with general anesthesia

You may not qualify if:

  • Patients with caesarean section, pregnancy story and chronic pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziosmanpasa University

Tokat Province, 60200, Turkey (Türkiye)

Location

MeSH Terms

Interventions

MorphineAnalgesics, Opioid

Intervention Hierarchy (Ancestors)

Morphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic CompoundsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic CompoundsNarcoticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesAnalgesicsSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic Uses

Study Officials

  • Hakan Tapar

    Assistant professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

April 18, 2017

First Posted

May 12, 2017

Study Start

April 18, 2017

Primary Completion

January 20, 2018

Study Completion

February 19, 2018

Last Updated

February 20, 2018

Record last verified: 2018-02

Locations

TU(1)